Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Ltd has announced the closure of its trading window for designated persons with immediate effect, in line with SEBI's Insider Trading Regulations. The closure covers the period leading up to the declaration of financial results for the quarter and half year ended September 30, 2025. The window will reopen 48 hours after the financial results are officially declared. The date of the board meeting to consider and approve these results will be communicated separately. The intimation was signed by Umang Gosalia, Managing Director of the company.
This is a routine compliance filing and does not have a direct impact on shareholders. However, it signals that the company's Q2 and H1 FY26 results are due soon, which may be a relevant event for investors to track.